Moderna Halts Construction of Japan mRNA Facility Citing Hostile Business Environment and Global Uncertainty
Moderna Inc. has terminated plans to build a large-scale mRNA drug manufacturing facility in Japan’s Kanagawa Prefecture, just over a year after first announcing the project. The plant was intended to enhance Japan’s domestic vaccine supply resilience and support Moderna’s expansion in Asia. However, the company cited a “deteriorating global and domestic business climate,” highlighting […]










